LB Pharmaceuticals: Funding, Investors & Team (Oct 2026)
LB Pharmaceuticals is a company in the early stages of development in the field of life sciences. They are committed to bringing innovative and enhanced versions of successful treatments for central nervous system disorders to the United States market. These treatments have been widely used in other countries but have never been developed, approved, or introduced in the US. LB Pharmaceuticals aims to establish a research-oriented entity focused on creating new intellectual property related to improving these previously successful medications.
LB Pharmaceuticals has raised $215M across 3 funding rounds on record, the most recent an undisclosed round of $100M announced in Feb 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
LB Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Feb 2026.
LB Pharmaceuticals Funding Rounds
LB Pharmaceuticals raised $40.0M in an undisclosed round announced in Sep 2023.
4 months later, a Series C of $75.0M was announced in Jan 2024.
2.1 years later, an undisclosed round of $100M was announced in Feb 2026.
LB Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
LB Pharmaceuticals Funding Compared to Other Biotechnology Startups
LB Pharmaceuticals' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LB Pharmaceuticals in Biotechnology and New York
Companies Similar to LB Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
LB Pharmaceuticals Funding FAQs
What does LB Pharmaceuticals do?
LB Pharmaceuticals is a company in the early stages of development in the field of life sciences. They are committed to bringing innovative and enhanced versions of successful treatments for central nervous system disorders to the United States market. These treatments have been widely used in other countries but have never been developed, approved, or introduced in the US. LB Pharmaceuticals aims to establish a research-oriented entity focused on creating new intellectual property related to improving these previously successful medications.
How much funding has LB Pharmaceuticals raised?
LB Pharmaceuticals has raised $215M across 3 rounds on record. The most recent is an undisclosed round of $100M announced in Feb 2026.
When did LB Pharmaceuticals last raise funding?
LB Pharmaceuticals' most recent funding round on record is an undisclosed round of $100M, announced in Feb 2026.
Who founded LB Pharmaceuticals?
FundedIQ lists Zachary Prensky (Founder) at LB Pharmaceuticals.
Where is LB Pharmaceuticals headquartered?
LB Pharmaceuticals is based in New York, United States.
How many employees does LB Pharmaceuticals have?
LB Pharmaceuticals is in the 11-50 employee band.
How does LB Pharmaceuticals' funding compare to other Biotechnology startups?
LB Pharmaceuticals' latest round of $100M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's LB Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LB Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.